Actively Recruiting
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Led by H. Lee Moffitt Cancer Center and Research Institute · Updated on 2026-02-09
35
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
Sponsors
H
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor
N
National Pediatric Cancer Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.
CONDITIONS
Official Title
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant must be considered likely incurable given the standard of care, including newly diagnosed, relapsed, in remission but at high risk of recurrence, or with suboptimal responses to previous therapy.
- Age-appropriate performance status: Karnofsky score 50 or more for patients 16 years or older, or Lansky score 50 or more for patients under 16.
- Participant and/or parents or legal guardian and primary oncologist must be willing to consider therapeutic strategies recommended by the pedsETB.
- Participant must be willing to be followed over time and allow collection of clinical data including scans, blood and lab samples, with optional serial blood sampling.
- All participants and/or their parents or legal guardians must understand and be willing to sign a written informed consent or assent document.
You will not qualify if you...
- Participants without known therapies to reliably induce a response are excluded and should seek clinical trials.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Moffitt Cancer Center
Tampa, Florida, United States, 33612
Actively Recruiting
Research Team
J
Jessica Crimella
CONTACT
J
Jonathan Metts, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here